Overall rank by patents
#5,030
of 49,997 tracked assignees
USPTO PatentsView assignee record - 69 granted patents across 33 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Oura ranks #5,030 of 49,997 tracked US assignees by granted-patent volume, with 69 patents across 33 technology areas.
USPTO PatentsView assignee plate
Corpus R5030 · Foreign Corporation #5,030 · 69 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-STRONG · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Mbda France (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Aerostar International · near
63 score
iFIT · near
63 score
Japan Tobacco · near
63 score
Oura Health Oy · this assignee
63 score
Ansys · near
63 score
3D Lighting… · lowest
7 score
What this shows Oura's Innovation Score is 63.2/100 (top 2% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Oura Health Oy is a focused PatentsView assignee: 33 CPC subclasses with 47.8% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (19 grants) versus a trough of 3 in 2021. By volume, Oura sits between Mbda France and SEI Optifrontier Co., Ltd..
Oura Health Oy shows 30 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Mbda France
69 patents
National University Corporation Okayama University
69 patents
Netspeed Systems, Inc.
69 patents
Oclaro Japan, Inc.
69 patents
PAX Labs, Inc.
69 patents
RFMicron, Inc.
69 patents
Rebellions Inc.
69 patents
SEI Optifrontier Co., Ltd.
69 patents
Oura Health Oy
69 patents
What this shows Oura holds 69 patents at rank #5,030, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #5,030 in granted patent volume.
Other assignees with the most granted patents in Oura's primary technology class.
Two PlainPatent-derived peer sets for Oura, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (63 here).
Nearest assignees by average claims per patent (13.7 here).
Oura's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
63 Top 2% higher than 98% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 4 | 5.8% |
| 2020 | 4 | 5.8% |
| 2021 | 3 | 4.3% |
| 2022 | 3 | 4.3% |
| 2023 | 8 | 11.6% |
| 2024 | 19 | 27.5% |
| 2025partial year | 28 | 40.6% |
Top 15 of 33 technology areas
Overall rank by patents
#5,030
of 49,997 tracked assignees
63.2 out of 100
What to do with this data
Oura Health Oy's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.